- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CT beats fluoroscopy for Crohn's disease anomalies
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
The big advantage of CT enteroclysis is its ability to detect complications that exist outside normal parameters of the diagnosis and identification of Crohn's disease, according to principal investigator Dr. Johannes Sailer, a radiologist at the Medical University of Vienna.
Researchers evaluated with both techniques 50 symptomatic patients. Results were matched with surgery and follow-up (AJR 2005;185;1575-1581). CT enteroclysis proved better than conventional enteroclysis at detecting fistulae, abscesses, and conglomeration of small bowel loops. CT enteroclysis also proved equivalent to standard imaging in the detection of minimal mucosal changes.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
